Systems Biology of Amyotrophic Lateral Sclerosis (ALS)

Not yet recruiting

• Conditions: ALS; ALS (Amyotrophic Lateral Sclerosis)

• Registration Number: NCT07007390
• Lead Sponsor: Viome

Brief Summary

The goal of this observational study is to identify molecular features in multiple clinical samples and/or the patient environment that are associated with ALS. Participants will collect biological samples and answer questionnaires regarding their health at each appointment with their ALS practitioner.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2025-03-28
• Status Verified: 2025-06
• Study Start: 2025-06-01
• Study First Submitted QC: 2025-06-02
• Last Update Submitted: 2025-06-02
• Study First Posted: 2025-06-05
• Last Update Posted: 2025-06-05
• Primary Completion: 2030-02-01
• Study Completion: 2030-05-01

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Patient of Dr. Espíndola at UFSC

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Molecular features of biological samples that are predictive of ALS progression	We will collect samples and health data from each participant from the time of diagnosis to their death or study termination, whichever comes sooner. Specific time frame: We will collect outcome measures through study completion, an average of 3 years.